title: Chloroquine prophylaxis, iron-folic acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on maternal parasitaemia and haemoglobin levels and on birthweight.
abstract: The effects of weekly chloroquine prophylaxis, daily iron-weekly folic acid supplementation or passive case management on maternal haemoglobin and parasitaemia and on birthweight were examined in primigravidae in a randomized, double-blind placebo-controlled intervention trial in 1996-98 in Hoima District, western Uganda. Iron-folic acid supplementation significantly increased mean birthweight as compared to case management (P = 0.03). Low birthweight (< 2.5 kg) occurred in 2% of babies of women receiving chloroquine prophylaxis for > or = 8 weeks and in 9% in the case management group (RR = 0.36, 95% CI 0.13-1.00, P = 0.009). Parasitaemia at enrolment significantly correlated with low birthweight in the case management group as compared to the intervention groups (P = 0.02). Women in the case management group who were parasitaemia and had haemoglobin levels < 100 g/L at delivery had babies with lower mean birthweight as compared to babies in the other groups (P = 0.04). Low haemoglobin level at enrolment, irrespective of parasitaemia status, was a predictor of low birthweight in the case management group only (P = 0.04). Chloroquine prophylaxis and iron-folic acid supplementation significantly increased maternal haemoglobin levels during pregnancy as compared to case management (P = 0.01 and 0.007, respectively) and the increase correlated to the duration of the intervention.
authors: Vector Control Division, Kampala, Uganda.
authors: R
authors: R
authors: Ndyomugyenyi
authors: P
authors: P
authors: Magnussen
mesh_terms: D000293:Adolescent; D000740:Anemia / Q000097:blood / Q000469:parasitology / Q000517:prevention & control; D000962:Antimalarials / Q000627:therapeutic use*; D001724:Birth Weight; D002738:Chloroquine / Q000627:therapeutic use*; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D008288:Malaria / Q000097:blood / Q000517:prevention & control*; D018512:Parasitemia / Q000517:prevention & control; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood / Q000469:parasitology / Q000517:prevention & control; D015597:Pregnancy Complications, Parasitic / Q000097:blood / Q000517:prevention & control*; D014454:Uganda
chemical_list: D000962:Antimalarials; D006454:Hemoglobins; D002738:Chloroquine; D005492:Folic Acid; D007501:Iron